Novartis cuts 275 jobs at Illinois site to consolidate Zolgensma manufacturing in North Carolina

As Novartis continues to reshape itself, the company is shutting the doors to one of its gene therapy manufacturing sites in the US.

The closure of a site in Libertyville, IL, a city to the northeast of Chicago, follows a “comprehensive manufacturing site network evaluation,” the company said in a statement to Endpoints News.